Physician profile
Maribeth Walter
NPI 1396281549
$892.82
in general payments reported to CMS, 2019-2025
15 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.27 · 2022: $62.15 · 2023: $250 · 2024: $314 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $207.05 | 2024-2025 | Watchman Flx, Bodyguardian |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.72 | 2023-2025 | Lifevest |
| Amgen INC. | $133.80 | 2021-2025 | Repatha |
| Kestra Medical Technology Services, INC. | $76.60 | 2024-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $66.79 | 2021-2023 | Xarelto |
| Philips North America LLC | $55.34 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $43.16 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $31.25 | 2023-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $27.26 | 2023-2024 | Farxiga, Wainua |
| Scpharmaceuticals INC. | $21.72 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.00 | 2025 | |
| Esperion Therapeutics, INC. | $15.54 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.14 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $14.51 | 2021 | |
| Pfizer INC. | $12.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maribeth Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.